Oculodentodigital dysplasia
(Redirected from ODDD)
Oculodentodigital dysplasia (ODDD) is a rare genetic disorder that affects the development of the eyes, teeth, and fingers. It is characterized by a range of symptoms, including small eyes (microphthalmia), dental abnormalities, and syndactyly (fusion of the fingers and toes). The condition is caused by mutations in the GJA1 gene, which provides instructions for making a protein called connexin 43. This protein is found in many tissues and organs, including the eyes, teeth, and digits, and is involved in cell communication.
Symptoms[edit | edit source]
The symptoms of ODDD can vary widely between individuals. Some people may have only mild symptoms, while others may have severe symptoms. The most common symptoms include:
- Small eyes (microphthalmia)
- Dental abnormalities, such as small or missing teeth
- Syndactyly, or fusion of the fingers and toes
- Thin nose with a pointed tip
- Neurological problems, such as seizures or intellectual disability
Causes[edit | edit source]
ODDD is caused by mutations in the GJA1 gene. This gene provides instructions for making a protein called connexin 43, which is found in many tissues and organs, including the eyes, teeth, and digits. Connexin 43 is involved in cell communication, and mutations in the GJA1 gene can disrupt this communication, leading to the symptoms of ODDD.
Diagnosis[edit | edit source]
Diagnosis of ODDD is based on the presence of characteristic symptoms and can be confirmed by genetic testing. Genetic testing can identify mutations in the GJA1 gene, confirming the diagnosis.
Treatment[edit | edit source]
There is currently no cure for ODDD. Treatment is focused on managing the symptoms and improving quality of life. This may include surgery to correct dental abnormalities or syndactyly, and medication to manage neurological symptoms.
See also[edit | edit source]
References[edit | edit source]
Oculodentodigital dysplasia Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD